DRAXIN Antikörper (Cy3)
Kurzübersicht für DRAXIN Antikörper (Cy3) (ABIN1419407)
Target
Alle DRAXIN Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human C1orf187
-
Isotyp
- IgG
-
-
anti-Dorsal Inhibitory Axon Guidance Protein (DRAXIN) (AA 227-276) antibody
DRAXIN Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Dorsal Inhibitory Axon Guidance Protein (DRAXIN) (C-Term) antibodyDRAXIN Reaktivität: Human, Maus, Ratte WB, IHC (p), IF, EIA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- IF(IHC-P) 1:50-200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- DRAXIN (Dorsal Inhibitory Axon Guidance Protein (DRAXIN))
-
Andere Bezeichnung
- C1orf187
-
Hintergrund
-
Synonyms: AGPA3119, C1orf187, Chromosome 1 open reading frame 187, Dorsal repulsive axon guidance protein, DRAXI_HUMAN, Draxin, Neucrin, UNQ3119.
Background: Chemorepulsive axon guidance protein required for the development of spinal cord and forebrain commissures. Acts as a chemorepulsive guidance protein for commissural axons during development. Able to inhibit or repel neurite outgrowth from dorsal spinal cord. Inhibits the stabilization of cytosolic beta-catenin (CTNNB1) via its interaction with LRP6, thereby acting as an antagonist of Wnt signaling pathway.
-
Gen-ID
- 374946
Target
-
